Editas Medicine
Danielle Hiner, PharmD, RPh, currently serves as Senior Manager of Medical Affairs at Editas Medicine and as a Medical Affairs Consultant at KorInsight, Inc., both positions held since July 2023. Previously, Danielle was the Manager of US Medical Affairs at Amryt Pharma from May 2021 to April 2023 and completed a Medical Affairs Postdoctoral Fellowship there. Danielle also contributed as Adjunct Faculty at Northeastern University in early 2022 and supported COVID-19 vaccine distribution as a Pharmacist at CVS Health in late 2020. Danielle's early career included roles as Lead Student Researcher at Midwestern University and Pharmacy Intern at UnitedRx. Academic qualifications include a Doctor of Pharmacy from Midwestern University and a Bachelor's Degree in Human Biology from the University of California, Merced.
This person is not in the org chart
This person is not in any offices
Editas Medicine
5 followers
Editas Medicine is a leading genome editing company focused on translating the power and promise of our proprietary genome editing systems into medicines to help transform the lives of people with genetically-defined diseases. Their goal is to discover, develop, manufacture, and commercialize transformative medicines for a range of serious diseases, including eye diseases, blood diseases, and cancer.